We invest in technology businesses that enhance personal well-being, improve care delivery, empower financial stability, leverage data systems for deep learning, and revolutionize the way we engage in commerce.
Investment Thesis
Why We Invest
We believe in the power of collaboration, and we like to put our money where our mouth is. An investment with Remedy can be used to increase product velocity while extending a company’s runway. Our goal is to help portfolio companies hit milestones faster and get to the next round with a higher valuation.
How We Invest
We have two investment approaches at Remedy:
-
CVC investments, off our balance sheet. These investments are strategic in nature and are always tied to a services relationship with our Product Studio.
-
Syndicate investments, raised through SPVs. Not necessarily tied to a services relationship with Remedy Product Studio.
Similar to VC funds, each prospective investment opportunity will undergo a diligence process before we choose to invest.
What Sets Us Apart
Our leadership team is made up of both product operators and former Venture Capitalists. Our experience working with venture-backed startups from both angles gives us insight into what a company needs to build a sustainable business and successfully raise its next round of funding. Many of our Partners have been acquired (ClassPass by MindBody), raised growth-equity funding (H1 Insights), and secured category-defining valuations in the earliest stages (Caraway).
Pitch Prep
Holistic Support
Remedy helps our Partners prepare for fundraising by assisting with investor readiness activities such as narrative development, pitch deck creation, dataroom organization, technical due-diligence, and investor relations/venture targeting.
Introductions
We help our partners increase visibility on their fundraises by actively connecting startups with investors in our network through our longstanding relationships as product partners and co-investors. In addition, we keep an active network of complementary service partners.
Incubation
On a limited basis, Remedy incubates companies with talented entrepreneurs who are looking for a technical co-founder. Ideal companies for this program are pre-launch or post proof-of-concept businesses in healthtech, fintech, wellness, or commerce.
Our Investment Team
Investment Portfolio
We believe in the quality of our work and are willing to put our money where our mouth is to back it—just ask our partners and portfolio companies. We got tired of seeing our partners go on to get acquired and exit after years of working together, without shared upside to celebrate those wins.
-
Strategic alignment: Our investment model works best for businesses that plan to use capital from their fundraise toward a product build or expansion of their technical team.
-
Round size: $1.5M+, with an institutional lead in place
-
Stage: Seed through Series A (occasionally, we will make exceptions for pre-seed founders with stellar track records)
-
Traction: Ideally, generating revenue or a clear path to revenue in 6 months. OR Businesses that have achieved PMF with an MVP in market and are seeing repeatable MoM usage from beta clients and have LOIs in hand with clear commitment dates. Note: We do not have hard-line revenue targets, but the momentum must be clear.
-
Founder Archetype: Mature founders that either have (1) deep professional experience in the industry in which they’re building, (2) extensive lived experience with the problem they aim to solve, or (3) previous experience founding a company
-
Nice to haves: (1) $500K of previous investment from a prior round, (2) technical leadership in place
-
We have two investment approaches at Remedy:
-
CVC investments off our balance sheet that are tied to a services relationship. Our CVC investment decisions can be made in ~2 weeks.
-
Syndicate investments that are not tied to a services relationship and are raised through SPVs. Our syndicate investments can take 4-6 weeks as we raise from external LPs.
-
-
CVC: Our check sizes scale up to $200K and are deployed in equal chunks (wired as cash) over the SOW period, usually 6-12 months
-
Syndicates: Check sizes are determined by investor interest, usually within the range of $100K - $500K. As we grow our LP base, we hope to increase this allocation.
-
-
We do not set valuations or lead rounds. We are minority, follow-on investors and typically the last check in.
-
We rarely invest in pre-seed, pre-revenue businesses, but will sometimes make exceptions for founders with a strong track record or businesses that are highly defensible
-
We will do 6-8 investments per year under our CVC model. We will do 4-6 investments per year out of the Remedy Syndicate. Note: these deals might overlap, but not necessarily. E.g., investments through our syndicate don’t need to be (but can be) client partners or portcos of Remedy’s CVC.
We invest in technology businesses that enhance personal wellbeing, improve care delivery, empower financial stability, revolutionize how we engage in commerce, and leverage data for global good. With a focus on these pivotal sectors – health, wellness, finance, commerce, and data – we aspire to build a brighter and more equitable global community, where health thrives, financial barriers dissolve, and commerce becomes a force for positive transformation.
N/A - However, we most commonly invest in US-based businesses.
Investment FAQs
"Remedy has been amazing. The team is incredibly professional and detail-oriented. I’ve enjoyed my time working with everyone in the organization, and they are a big part of the AssetDash plans moving forward. I’m excited to have Remedy on-board as an investor and long-term partner."
Testimonials
Founders, we want to hear from you!
Investors, sign up to receive deal flow
Remedy's access to both early stage companies and a network of investors means we often get to facilitate relevant (and successful) VC<>founder introductions. We regularly share deals with investors who we think might be a fit for the companies we meet. Sign up to receive these deal blasts, and join our community!